Lantheus Holdings (LNTH) Other financing activities (2015 - 2026)
Lantheus Holdings (LNTH) posted quarterly Other financing activities of $2.6 million for Q1 2026, up 194.36% quarter-over-quarter from -$2.7 million in Q4 2025.
Lantheus Holdings (LNTH) Other financing activities (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Other financing activities for 12 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $6.3 million (up 151.11% YoY), while the FY2025 annual figure was $3.7 million, up 8.03% from the prior year.
- Other financing activities grew to $2.6 million in Q1 2026 per LNTH's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $5.4 million in Q1 2022 and bottomed at -$2.7 million in Q4 2025.
- Historically, Other financing activities has averaged $1.4 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2022 — Other financing activities sank 100.15% — and 2023, when it jumped 35500.0%.
- Lantheus Holdings' Other financing activities stood at -$1000.0 in 2022, then surged by 35500.0% to $354000.0 in 2023, then soared by 173.16% to $967000.0 in 2024, then plunged by 383.97% to -$2.7 million in 2025, then surged by 194.36% to $2.6 million in 2026.
- Business Quant data shows LNTH's Other financing activities at $2.6 million in Q1 2026, -$2.7 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96 Mn |
| Jun 30, 2026 | 5.96 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Sep 30, 2024 | 967,000.00 |
| Sep 30, 2024 | 967,000.00 |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 934,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 354,000.00 |
| Dec 31, 2023 | 354,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Sep 30, 2023 | 273,000.00 |